VENT-03 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07 (month) in 9d
ESTIMATED |
READOUT
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With
Phase 2 · Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus |
Ventus Therapeutics U.S., Inc. | VENT-03 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|